NASDAQ Exchange Sends The Nasdaq Stock Market -- Maryland a Warning Letter
Oncothyreon Inc. said it has received a letter from the NASDAQ stock exchange, warning that the biotech is not in compliance with requirements to stay on the exchange’s Global Market and that it could be moved to the Capital Market.